COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management

J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e376-e378. doi: 10.1111/jdv.16625. Epub 2020 Jun 4.

Authors

C Mugheddu¹, L Pizzatti¹, S Sanna¹, L Atzori¹, F Rongioletti¹

Affiliation

¹ Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Betacoronavirus / isolation & purification*
COVID-19
Coronavirus Infections / complications*
Coronavirus Infections / virology
Critical Care / organization & administration*
Dermatitis, Exfoliative / complications
Dermatitis, Exfoliative / drug therapy*
Humans
Male
Middle Aged
Pandemics
Pneumonia, Viral / complications*
Pneumonia, Viral / virology
Psoriasis / complications
Psoriasis / drug therapy*
SARS-CoV-2
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast